Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graves Ophthalmopathy | 24 | 2024 | 135 | 11.100 |
Why?
|
Orbital Neoplasms | 21 | 2024 | 223 | 6.130 |
Why?
|
Eyelids | 21 | 2024 | 278 | 5.980 |
Why?
|
Orbit | 22 | 2024 | 459 | 4.690 |
Why?
|
Eyelid Diseases | 16 | 2024 | 155 | 4.510 |
Why?
|
Orbital Diseases | 12 | 2022 | 178 | 4.190 |
Why?
|
Exophthalmos | 7 | 2024 | 100 | 3.240 |
Why?
|
Eyelid Neoplasms | 9 | 2022 | 88 | 3.220 |
Why?
|
Ophthalmologic Surgical Procedures | 12 | 2024 | 354 | 2.810 |
Why?
|
Oculomotor Muscles | 7 | 2023 | 405 | 2.680 |
Why?
|
Dacryocystorhinostomy | 9 | 2018 | 78 | 2.520 |
Why?
|
Conjunctival Neoplasms | 7 | 2024 | 78 | 2.490 |
Why?
|
Nasolacrimal Duct | 10 | 2018 | 79 | 2.310 |
Why?
|
Lacrimal Apparatus | 8 | 2024 | 224 | 2.150 |
Why?
|
Conjunctiva | 8 | 2022 | 477 | 2.110 |
Why?
|
Blepharoplasty | 7 | 2024 | 59 | 1.990 |
Why?
|
Endoscopy | 18 | 2023 | 1854 | 1.770 |
Why?
|
Ectropion | 4 | 2020 | 27 | 1.730 |
Why?
|
Optic Nerve Diseases | 5 | 2021 | 342 | 1.730 |
Why?
|
Orbital Pseudotumor | 4 | 2016 | 42 | 1.630 |
Why?
|
Lacrimal Apparatus Diseases | 6 | 2024 | 72 | 1.590 |
Why?
|
Orbital Implants | 4 | 2021 | 20 | 1.490 |
Why?
|
Ophthalmology | 15 | 2024 | 560 | 1.490 |
Why?
|
Blepharoptosis | 7 | 2021 | 144 | 1.450 |
Why?
|
Eye Diseases | 3 | 2022 | 660 | 1.390 |
Why?
|
Eye Infections, Bacterial | 4 | 2017 | 239 | 1.360 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 3 | 2023 | 113 | 1.360 |
Why?
|
Mucormycosis | 3 | 2022 | 102 | 1.350 |
Why?
|
Entropion | 3 | 2020 | 9 | 1.300 |
Why?
|
Visual Fields | 5 | 2020 | 1065 | 1.290 |
Why?
|
Orbital Fractures | 4 | 2020 | 108 | 1.250 |
Why?
|
Lacrimal Duct Obstruction | 5 | 2016 | 53 | 1.190 |
Why?
|
Intubation | 3 | 2019 | 140 | 1.120 |
Why?
|
Orbital Cellulitis | 4 | 2015 | 33 | 1.120 |
Why?
|
Dacryocystitis | 3 | 2017 | 68 | 1.030 |
Why?
|
Neurilemmoma | 3 | 2020 | 522 | 1.000 |
Why?
|
Eyebrows | 2 | 2017 | 38 | 0.970 |
Why?
|
Hemangioma, Cavernous | 4 | 2023 | 107 | 0.950 |
Why?
|
Decompression, Surgical | 6 | 2023 | 603 | 0.950 |
Why?
|
Eye Neoplasms | 3 | 2019 | 306 | 0.950 |
Why?
|
Corneal Diseases | 3 | 2019 | 535 | 0.870 |
Why?
|
Sphenoid Bone | 4 | 2021 | 176 | 0.860 |
Why?
|
Diplopia | 7 | 2024 | 217 | 0.860 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2020 | 737 | 0.860 |
Why?
|
Nasal Cavity | 3 | 2016 | 310 | 0.850 |
Why?
|
Mucorales | 2 | 2022 | 35 | 0.830 |
Why?
|
Vision Disorders | 3 | 2019 | 1093 | 0.810 |
Why?
|
Hemochromatosis | 1 | 2024 | 175 | 0.810 |
Why?
|
Anophthalmos | 2 | 2021 | 23 | 0.780 |
Why?
|
Vascular Malformations | 2 | 2020 | 469 | 0.760 |
Why?
|
Minocycline | 1 | 2022 | 170 | 0.760 |
Why?
|
Keratoacanthoma | 1 | 2021 | 33 | 0.740 |
Why?
|
Hyperpigmentation | 1 | 2022 | 116 | 0.740 |
Why?
|
Suture Techniques | 3 | 2014 | 775 | 0.720 |
Why?
|
Humans | 159 | 2024 | 768166 | 0.690 |
Why?
|
Frail Elderly | 2 | 2016 | 781 | 0.690 |
Why?
|
Imidazoles | 2 | 2017 | 1169 | 0.680 |
Why?
|
Hydroxychloroquine | 1 | 2024 | 426 | 0.670 |
Why?
|
Tomography, X-Ray Computed | 24 | 2021 | 20760 | 0.660 |
Why?
|
Ophthalmic Nerve | 1 | 2019 | 42 | 0.650 |
Why?
|
Cysts | 4 | 2018 | 685 | 0.650 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2019 | 53 | 0.640 |
Why?
|
Biopsy | 11 | 2020 | 6793 | 0.620 |
Why?
|
Eye Injuries | 4 | 2019 | 228 | 0.620 |
Why?
|
Lymphatic Abnormalities | 1 | 2020 | 134 | 0.620 |
Why?
|
Eye Infections, Fungal | 2 | 2016 | 99 | 0.600 |
Why?
|
Factor XIIIa | 1 | 2017 | 10 | 0.600 |
Why?
|
Technology Assessment, Biomedical | 5 | 2021 | 312 | 0.600 |
Why?
|
Horner Syndrome | 1 | 2018 | 35 | 0.590 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2018 | 180 | 0.590 |
Why?
|
Retrospective Studies | 52 | 2024 | 81762 | 0.590 |
Why?
|
Eye, Artificial | 1 | 2017 | 18 | 0.590 |
Why?
|
Blepharophimosis | 1 | 2017 | 21 | 0.590 |
Why?
|
Academies and Institutes | 9 | 2024 | 326 | 0.580 |
Why?
|
Sarcoma, Myeloid | 1 | 2018 | 52 | 0.580 |
Why?
|
Nerve Transfer | 1 | 2019 | 132 | 0.580 |
Why?
|
Nevus | 1 | 2019 | 205 | 0.580 |
Why?
|
Dermoid Cyst | 1 | 2018 | 92 | 0.570 |
Why?
|
Ectodermal Dysplasia | 1 | 2018 | 107 | 0.570 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2017 | 64 | 0.570 |
Why?
|
Eye Hemorrhage | 1 | 2017 | 19 | 0.570 |
Why?
|
Retinal Vein Occlusion | 1 | 2018 | 149 | 0.560 |
Why?
|
Middle Aged | 69 | 2024 | 223492 | 0.560 |
Why?
|
Skull Neoplasms | 1 | 2018 | 173 | 0.560 |
Why?
|
Cranial Nerve Diseases | 1 | 2017 | 111 | 0.560 |
Why?
|
Orbit Evisceration | 1 | 2016 | 9 | 0.540 |
Why?
|
Fasciitis, Necrotizing | 1 | 2017 | 79 | 0.540 |
Why?
|
Port-Wine Stain | 1 | 2016 | 33 | 0.540 |
Why?
|
Eye Foreign Bodies | 1 | 2017 | 51 | 0.530 |
Why?
|
Pyoderma Gangrenosum | 1 | 2017 | 84 | 0.530 |
Why?
|
Cicatrix | 3 | 2019 | 798 | 0.530 |
Why?
|
Dermis | 1 | 2017 | 203 | 0.530 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 283 | 0.520 |
Why?
|
Maxillary Sinus | 2 | 2014 | 175 | 0.520 |
Why?
|
Male | 83 | 2024 | 364719 | 0.520 |
Why?
|
Surgical Sponges | 1 | 2016 | 40 | 0.520 |
Why?
|
Choroid | 1 | 2018 | 364 | 0.520 |
Why?
|
Debridement | 3 | 2017 | 494 | 0.510 |
Why?
|
Oximes | 1 | 2017 | 303 | 0.510 |
Why?
|
Sphenoid Sinus | 2 | 2018 | 101 | 0.510 |
Why?
|
Skin Neoplasms | 5 | 2024 | 5863 | 0.510 |
Why?
|
Erythema | 1 | 2017 | 261 | 0.510 |
Why?
|
Tomography, Optical Coherence | 3 | 2019 | 2957 | 0.500 |
Why?
|
Nerve Compression Syndromes | 1 | 2017 | 160 | 0.500 |
Why?
|
Sutures | 2 | 2014 | 282 | 0.500 |
Why?
|
Mydriatics | 1 | 2015 | 67 | 0.500 |
Why?
|
Ethmoid Sinus | 1 | 2015 | 58 | 0.490 |
Why?
|
Antigens, CD34 | 1 | 2017 | 657 | 0.490 |
Why?
|
Prosthesis Implantation | 3 | 2021 | 594 | 0.490 |
Why?
|
Melanoma | 4 | 2024 | 5706 | 0.490 |
Why?
|
Oculomotor Nerve | 2 | 2019 | 72 | 0.490 |
Why?
|
Paranasal Sinus Diseases | 2 | 2021 | 121 | 0.480 |
Why?
|
Phenylephrine | 1 | 2015 | 292 | 0.480 |
Why?
|
Glucocorticoids | 6 | 2022 | 2167 | 0.480 |
Why?
|
Pyrimidinones | 1 | 2017 | 386 | 0.480 |
Why?
|
Contact Lenses | 1 | 2016 | 137 | 0.480 |
Why?
|
Rhabdomyosarcoma | 1 | 2017 | 358 | 0.470 |
Why?
|
Hernia | 1 | 2014 | 67 | 0.460 |
Why?
|
Aged, 80 and over | 25 | 2024 | 59629 | 0.460 |
Why?
|
Skin Transplantation | 2 | 2019 | 1096 | 0.460 |
Why?
|
Female | 81 | 2024 | 397192 | 0.460 |
Why?
|
Skin Aging | 1 | 2015 | 140 | 0.450 |
Why?
|
Myxoma | 1 | 2014 | 114 | 0.450 |
Why?
|
Eyelashes | 1 | 2014 | 20 | 0.450 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2018 | 594 | 0.450 |
Why?
|
Ophthalmic Artery | 1 | 2014 | 57 | 0.450 |
Why?
|
Alopecia | 1 | 2018 | 416 | 0.440 |
Why?
|
Eye Infections, Viral | 1 | 2014 | 61 | 0.440 |
Why?
|
Edema | 2 | 2017 | 765 | 0.440 |
Why?
|
Panophthalmitis | 1 | 2013 | 6 | 0.440 |
Why?
|
Hyperglycemia | 1 | 2022 | 1388 | 0.440 |
Why?
|
Nerve Regeneration | 1 | 2019 | 797 | 0.440 |
Why?
|
Fluorescein Angiography | 2 | 2018 | 1086 | 0.440 |
Why?
|
Facial Paralysis | 1 | 2017 | 346 | 0.430 |
Why?
|
Chalazion | 1 | 2013 | 10 | 0.430 |
Why?
|
Aged | 49 | 2024 | 171504 | 0.430 |
Why?
|
Alendronate | 1 | 2014 | 174 | 0.420 |
Why?
|
Keratins | 2 | 2016 | 499 | 0.410 |
Why?
|
Streptococcal Infections | 1 | 2017 | 619 | 0.410 |
Why?
|
Rhabdoid Tumor | 1 | 2014 | 211 | 0.410 |
Why?
|
Carcinoma | 2 | 2015 | 2332 | 0.410 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2914 | 0.400 |
Why?
|
Terminology as Topic | 1 | 2019 | 1542 | 0.400 |
Why?
|
Cornea | 2 | 2019 | 1316 | 0.400 |
Why?
|
Emphysema | 1 | 2015 | 236 | 0.400 |
Why?
|
Muscle Weakness | 1 | 2015 | 412 | 0.390 |
Why?
|
Fever | 3 | 2021 | 1614 | 0.390 |
Why?
|
Pyridones | 1 | 2017 | 819 | 0.390 |
Why?
|
Surgical Flaps | 6 | 2022 | 1682 | 0.380 |
Why?
|
Keratosis, Actinic | 1 | 2012 | 71 | 0.380 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 704 | 0.360 |
Why?
|
Adipose Tissue | 3 | 2021 | 3329 | 0.350 |
Why?
|
Nose | 3 | 2023 | 522 | 0.340 |
Why?
|
Foreign Bodies | 1 | 2014 | 403 | 0.340 |
Why?
|
Cocaine-Related Disorders | 1 | 2013 | 458 | 0.340 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2015 | 580 | 0.330 |
Why?
|
Neuroblastoma | 1 | 2018 | 1266 | 0.330 |
Why?
|
Immunohistochemistry | 6 | 2019 | 11095 | 0.330 |
Why?
|
Diphosphonates | 1 | 2014 | 634 | 0.330 |
Why?
|
Blindness | 1 | 2013 | 587 | 0.320 |
Why?
|
Escherichia coli Infections | 1 | 2013 | 524 | 0.320 |
Why?
|
Strabismus | 2 | 2024 | 320 | 0.320 |
Why?
|
Lymph Nodes | 1 | 2020 | 3474 | 0.310 |
Why?
|
Football | 1 | 2014 | 506 | 0.310 |
Why?
|
Herpesvirus 4, Human | 1 | 2014 | 1082 | 0.310 |
Why?
|
Staphylococcal Infections | 1 | 2017 | 1398 | 0.310 |
Why?
|
Adult | 43 | 2024 | 223646 | 0.300 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2021 | 4058 | 0.300 |
Why?
|
Cocaine | 1 | 2013 | 947 | 0.300 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2819 | 0.300 |
Why?
|
Craniopharyngioma | 2 | 2001 | 279 | 0.300 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 1642 | 0.300 |
Why?
|
Visual Field Tests | 3 | 2019 | 415 | 0.300 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2014 | 617 | 0.290 |
Why?
|
B-Lymphocytes | 3 | 2018 | 4793 | 0.290 |
Why?
|
Retina | 1 | 2018 | 2662 | 0.290 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2059 | 0.290 |
Why?
|
Geriatric Assessment | 1 | 2015 | 1422 | 0.280 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1140 | 0.280 |
Why?
|
Dry Eye Syndromes | 2 | 2023 | 385 | 0.280 |
Why?
|
Eye Enucleation | 4 | 2021 | 128 | 0.280 |
Why?
|
Bone Density Conservation Agents | 1 | 2014 | 797 | 0.280 |
Why?
|
Antigens, CD | 1 | 2017 | 4035 | 0.280 |
Why?
|
Stents | 2 | 2019 | 3195 | 0.280 |
Why?
|
Self Report | 2 | 2016 | 3773 | 0.270 |
Why?
|
Hypesthesia | 2 | 2019 | 106 | 0.270 |
Why?
|
Anesthetics, Local | 1 | 2013 | 1005 | 0.270 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2014 | 2846 | 0.260 |
Why?
|
Magnetic Resonance Imaging | 19 | 2019 | 36743 | 0.250 |
Why?
|
Treatment Outcome | 19 | 2023 | 65371 | 0.250 |
Why?
|
Molecular Targeted Therapy | 2 | 2016 | 2830 | 0.250 |
Why?
|
Germany | 3 | 2016 | 883 | 0.250 |
Why?
|
Diagnosis, Differential | 9 | 2021 | 13014 | 0.250 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2565 | 0.250 |
Why?
|
Ultrasonography | 1 | 2019 | 6004 | 0.250 |
Why?
|
Conjunctival Diseases | 2 | 2016 | 109 | 0.250 |
Why?
|
Surgery, Plastic | 1 | 2012 | 652 | 0.250 |
Why?
|
Psychometrics | 1 | 2015 | 3063 | 0.250 |
Why?
|
Skin Abnormalities | 2 | 2017 | 60 | 0.240 |
Why?
|
Disease Management | 1 | 2016 | 2536 | 0.240 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 1560 | 0.240 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1437 | 0.240 |
Why?
|
Paranasal Sinuses | 2 | 2017 | 267 | 0.230 |
Why?
|
Nasal Mucosa | 2 | 2018 | 416 | 0.230 |
Why?
|
Follow-Up Studies | 13 | 2024 | 39348 | 0.220 |
Why?
|
Antineoplastic Agents | 5 | 2024 | 13676 | 0.220 |
Why?
|
Quality of Life | 5 | 2022 | 13490 | 0.220 |
Why?
|
Quality Improvement | 1 | 2019 | 3857 | 0.220 |
Why?
|
Conjunctivitis | 1 | 2024 | 153 | 0.220 |
Why?
|
Pigmentation Disorders | 1 | 2024 | 105 | 0.210 |
Why?
|
Epidermal Cyst | 2 | 2016 | 63 | 0.210 |
Why?
|
Retreatment | 1 | 2024 | 598 | 0.200 |
Why?
|
Receptors, Thyrotropin | 1 | 2022 | 45 | 0.200 |
Why?
|
Postoperative Complications | 6 | 2024 | 15832 | 0.200 |
Why?
|
Pituitary Neoplasms | 2 | 2001 | 1322 | 0.200 |
Why?
|
Materia Medica | 1 | 2021 | 14 | 0.190 |
Why?
|
Ecchymosis | 1 | 2021 | 32 | 0.190 |
Why?
|
Dioxygenases | 1 | 2024 | 353 | 0.190 |
Why?
|
Anilides | 1 | 2024 | 413 | 0.190 |
Why?
|
Face | 3 | 2023 | 1029 | 0.180 |
Why?
|
Otolaryngology | 2 | 2020 | 699 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5703 | 0.180 |
Why?
|
Salmonella enteritidis | 1 | 2000 | 16 | 0.180 |
Why?
|
Oxazolone | 1 | 2020 | 61 | 0.180 |
Why?
|
Systemic Vasculitis | 1 | 2020 | 37 | 0.180 |
Why?
|
Polyhydroxyethyl Methacrylate | 1 | 2019 | 30 | 0.170 |
Why?
|
Hedgehog Proteins | 1 | 2024 | 771 | 0.170 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 307 | 0.170 |
Why?
|
Streptavidin | 1 | 1999 | 81 | 0.160 |
Why?
|
Optic Nerve Injuries | 1 | 2020 | 150 | 0.160 |
Why?
|
Scleral Buckling | 1 | 2019 | 95 | 0.160 |
Why?
|
Maxillary Fractures | 1 | 2019 | 21 | 0.160 |
Why?
|
Zygomatic Fractures | 1 | 2019 | 35 | 0.160 |
Why?
|
Tears | 2 | 2020 | 254 | 0.160 |
Why?
|
Prevalence | 1 | 2016 | 15869 | 0.160 |
Why?
|
Sclerotherapy | 1 | 2020 | 183 | 0.160 |
Why?
|
Salmonella Infections | 1 | 2000 | 173 | 0.160 |
Why?
|
Food Contamination | 1 | 2000 | 193 | 0.160 |
Why?
|
Carcinoma, Basal Cell | 1 | 2024 | 565 | 0.160 |
Why?
|
Vitamin K | 1 | 2021 | 314 | 0.160 |
Why?
|
Rupture | 4 | 2014 | 444 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 219 | 0.150 |
Why?
|
Hemianopsia | 1 | 2000 | 121 | 0.150 |
Why?
|
Biotin | 1 | 1999 | 256 | 0.150 |
Why?
|
Facial Neoplasms | 1 | 2019 | 126 | 0.150 |
Why?
|
Palate, Hard | 1 | 2018 | 59 | 0.150 |
Why?
|
Drug Therapy, Combination | 3 | 2017 | 6316 | 0.150 |
Why?
|
Preoperative Period | 2 | 2017 | 565 | 0.150 |
Why?
|
Adolescent | 14 | 2023 | 89169 | 0.140 |
Why?
|
Blinking | 2 | 2017 | 135 | 0.140 |
Why?
|
Penicillin G | 1 | 2017 | 40 | 0.140 |
Why?
|
Plant Extracts | 1 | 2021 | 497 | 0.140 |
Why?
|
Corneal Ulcer | 2 | 2017 | 125 | 0.140 |
Why?
|
Combined Modality Therapy | 3 | 2017 | 8542 | 0.140 |
Why?
|
Sampling Studies | 1 | 2019 | 615 | 0.140 |
Why?
|
Lacerations | 1 | 2019 | 150 | 0.140 |
Why?
|
Nuclear Medicine | 1 | 2020 | 262 | 0.140 |
Why?
|
Submandibular Gland | 1 | 2017 | 85 | 0.140 |
Why?
|
Cadaver | 3 | 2019 | 1363 | 0.140 |
Why?
|
Fundus Oculi | 1 | 2018 | 560 | 0.140 |
Why?
|
Streptococcus | 1 | 2017 | 198 | 0.140 |
Why?
|
Cautery | 1 | 2017 | 73 | 0.130 |
Why?
|
Surgery, Computer-Assisted | 1 | 2024 | 1003 | 0.130 |
Why?
|
Optic Disk | 1 | 2020 | 421 | 0.130 |
Why?
|
Exanthema | 1 | 2021 | 503 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9419 | 0.130 |
Why?
|
Silicone Elastomers | 1 | 2016 | 78 | 0.130 |
Why?
|
Pigmentation | 1 | 2016 | 143 | 0.130 |
Why?
|
Carotid-Cavernous Sinus Fistula | 1 | 2016 | 35 | 0.130 |
Why?
|
Anti-Bacterial Agents | 4 | 2022 | 7477 | 0.130 |
Why?
|
Panuveitis | 1 | 2016 | 33 | 0.130 |
Why?
|
Visual Acuity | 6 | 2016 | 2714 | 0.130 |
Why?
|
Hospitals, Special | 1 | 2016 | 90 | 0.130 |
Why?
|
Eye Pain | 2 | 2013 | 46 | 0.130 |
Why?
|
Infant | 7 | 2023 | 36535 | 0.130 |
Why?
|
Models, Anatomic | 1 | 2019 | 680 | 0.130 |
Why?
|
Gels | 1 | 2017 | 423 | 0.130 |
Why?
|
Hair Diseases | 1 | 2016 | 72 | 0.130 |
Why?
|
Immunoglobulin G | 3 | 2023 | 4568 | 0.130 |
Why?
|
Melanosis | 1 | 2016 | 93 | 0.120 |
Why?
|
Histiocytes | 1 | 2015 | 97 | 0.120 |
Why?
|
Antibodies, Blocking | 1 | 2016 | 250 | 0.120 |
Why?
|
United States | 12 | 2024 | 73039 | 0.120 |
Why?
|
Frontal Lobe | 1 | 2001 | 1426 | 0.120 |
Why?
|
Silicones | 1 | 2016 | 228 | 0.120 |
Why?
|
Fusobacterium necrophorum | 1 | 2014 | 14 | 0.120 |
Why?
|
Lymphangiogenesis | 1 | 2016 | 171 | 0.120 |
Why?
|
Neovascularization, Pathologic | 2 | 2016 | 2631 | 0.120 |
Why?
|
Cavernous Sinus Thrombosis | 1 | 2014 | 14 | 0.120 |
Why?
|
Lemierre Syndrome | 1 | 2014 | 14 | 0.120 |
Why?
|
Eye Injuries, Penetrating | 3 | 1994 | 121 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 542 | 0.120 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2015 | 183 | 0.110 |
Why?
|
Glass | 1 | 2014 | 116 | 0.110 |
Why?
|
Societies, Medical | 2 | 2019 | 3968 | 0.110 |
Why?
|
Lymph Node Excision | 1 | 2020 | 1271 | 0.110 |
Why?
|
Antifungal Agents | 2 | 2016 | 761 | 0.110 |
Why?
|
Bioartificial Organs | 1 | 2014 | 47 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2024 | 1381 | 0.110 |
Why?
|
Vancomycin | 1 | 2017 | 506 | 0.110 |
Why?
|
Translating | 1 | 2015 | 144 | 0.110 |
Why?
|
Hair Follicle | 1 | 2016 | 219 | 0.110 |
Why?
|
Remission, Spontaneous | 1 | 2014 | 384 | 0.110 |
Why?
|
Eye Burns | 1 | 2014 | 64 | 0.110 |
Why?
|
Consensus | 2 | 2020 | 3212 | 0.110 |
Why?
|
Massachusetts | 2 | 2017 | 8890 | 0.110 |
Why?
|
Young Adult | 7 | 2018 | 60066 | 0.110 |
Why?
|
Parotid Gland | 1 | 2014 | 178 | 0.110 |
Why?
|
False Negative Reactions | 1 | 2015 | 574 | 0.110 |
Why?
|
Leiomyosarcoma | 1 | 2017 | 426 | 0.110 |
Why?
|
Prostaglandins, Synthetic | 1 | 2013 | 24 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2022 | 874 | 0.110 |
Why?
|
Documentation | 1 | 2020 | 917 | 0.110 |
Why?
|
Aspergillosis | 1 | 2015 | 242 | 0.110 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1972 | 0.110 |
Why?
|
Burns, Chemical | 1 | 2014 | 123 | 0.110 |
Why?
|
Viscosupplements | 1 | 2013 | 19 | 0.110 |
Why?
|
Granuloma, Foreign-Body | 1 | 2013 | 41 | 0.110 |
Why?
|
Sirolimus | 1 | 2020 | 1540 | 0.100 |
Why?
|
Carcinoma, Lobular | 1 | 2017 | 480 | 0.100 |
Why?
|
Endoscopes | 1 | 2013 | 169 | 0.100 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1703 | 0.100 |
Why?
|
Rupture, Spontaneous | 1 | 2013 | 365 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2894 | 0.100 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 9263 | 0.100 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2019 | 1232 | 0.100 |
Why?
|
Azithromycin | 1 | 2013 | 201 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 2 | 2021 | 1886 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 3 | 2017 | 4063 | 0.100 |
Why?
|
Ophthalmoplegia | 1 | 2013 | 168 | 0.100 |
Why?
|
Administration, Intranasal | 1 | 2013 | 485 | 0.090 |
Why?
|
Meningeal Neoplasms | 1 | 2020 | 1253 | 0.090 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2014 | 648 | 0.090 |
Why?
|
Nasopharyngeal Diseases | 1 | 2011 | 27 | 0.090 |
Why?
|
Child | 8 | 2020 | 80917 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2023 | 20227 | 0.090 |
Why?
|
Fluoroquinolones | 1 | 2013 | 309 | 0.090 |
Why?
|
Uveitis | 1 | 2015 | 398 | 0.090 |
Why?
|
Botulinum Toxins | 1 | 2013 | 191 | 0.090 |
Why?
|
Graft vs Host Disease | 1 | 2023 | 3049 | 0.090 |
Why?
|
Hemangioma | 1 | 2016 | 727 | 0.090 |
Why?
|
Abscess | 2 | 2014 | 606 | 0.090 |
Why?
|
Mycoses | 1 | 2014 | 386 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5432 | 0.090 |
Why?
|
Muscle Contraction | 1 | 2015 | 1209 | 0.090 |
Why?
|
Paraproteinemias | 1 | 2013 | 252 | 0.090 |
Why?
|
Inflammation | 4 | 2022 | 10873 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1103 | 0.090 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1903 | 0.090 |
Why?
|
Lymphocytes | 1 | 2018 | 2614 | 0.090 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11244 | 0.080 |
Why?
|
Breast Neoplasms | 3 | 2017 | 21206 | 0.080 |
Why?
|
Molecular Biology | 1 | 2013 | 573 | 0.080 |
Why?
|
Radiography | 3 | 2015 | 6983 | 0.080 |
Why?
|
Mohs Surgery | 1 | 2012 | 217 | 0.080 |
Why?
|
Infarction | 1 | 2011 | 247 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1640 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2016 | 1656 | 0.080 |
Why?
|
Gene Rearrangement | 1 | 2014 | 1146 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3514 | 0.080 |
Why?
|
Postoperative Care | 1 | 2015 | 1480 | 0.080 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1424 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1805 | 0.070 |
Why?
|
Lung Neoplasms | 3 | 2009 | 13586 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2020 | 2360 | 0.070 |
Why?
|
Sinusitis | 1 | 2015 | 997 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3603 | 0.060 |
Why?
|
Viral Load | 1 | 2014 | 3396 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6082 | 0.060 |
Why?
|
Meige Syndrome | 1 | 2004 | 12 | 0.060 |
Why?
|
Graft Survival | 1 | 2015 | 3887 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2009 | 1836 | 0.060 |
Why?
|
Radiodermatitis | 1 | 2024 | 61 | 0.060 |
Why?
|
Wound Healing | 1 | 2015 | 2809 | 0.060 |
Why?
|
Blepharospasm | 1 | 2004 | 34 | 0.060 |
Why?
|
Cyanobacteria | 1 | 2004 | 54 | 0.060 |
Why?
|
Amyloidosis | 1 | 2011 | 878 | 0.050 |
Why?
|
Infant, Newborn | 3 | 2018 | 26422 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2257 | 0.050 |
Why?
|
Glaucoma | 1 | 2013 | 1194 | 0.050 |
Why?
|
Immunotherapy | 1 | 2019 | 4755 | 0.050 |
Why?
|
Health Status | 1 | 2016 | 4091 | 0.050 |
Why?
|
Recurrence | 1 | 2015 | 8509 | 0.050 |
Why?
|
Antibodies, Viral | 1 | 2014 | 3216 | 0.050 |
Why?
|
Neuromuscular Agents | 1 | 2004 | 148 | 0.050 |
Why?
|
Radiotherapy | 1 | 2009 | 1502 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13671 | 0.050 |
Why?
|
Anemia, Sickle Cell | 1 | 2011 | 1065 | 0.050 |
Why?
|
Meibomian Glands | 1 | 2022 | 74 | 0.050 |
Why?
|
Health Surveys | 1 | 2012 | 4057 | 0.050 |
Why?
|
Dermatology | 1 | 2012 | 905 | 0.050 |
Why?
|
Survival Rate | 1 | 2016 | 12840 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18412 | 0.050 |
Why?
|
Philadelphia | 2 | 1992 | 271 | 0.050 |
Why?
|
Eye Evisceration | 1 | 2021 | 22 | 0.050 |
Why?
|
Neoplasm Seeding | 1 | 2001 | 85 | 0.050 |
Why?
|
Iopamidol | 1 | 2002 | 187 | 0.050 |
Why?
|
Cyclin A | 1 | 2001 | 59 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2015 | 1899 | 0.050 |
Why?
|
Uveal Neoplasms | 1 | 2024 | 344 | 0.050 |
Why?
|
Botulinum Toxins, Type A | 1 | 2004 | 238 | 0.040 |
Why?
|
Prognosis | 2 | 2020 | 30010 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2001 | 9118 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 992 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14729 | 0.040 |
Why?
|
Prospective Studies | 3 | 2020 | 54926 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2002 | 665 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2012 | 3620 | 0.040 |
Why?
|
Time Factors | 3 | 2016 | 40218 | 0.040 |
Why?
|
Salivary Glands | 1 | 2020 | 231 | 0.040 |
Why?
|
Eggs | 1 | 2000 | 182 | 0.040 |
Why?
|
Bioengineering | 1 | 2019 | 101 | 0.040 |
Why?
|
Hydrolysis | 1 | 2019 | 646 | 0.040 |
Why?
|
Echo-Planar Imaging | 1 | 2002 | 648 | 0.040 |
Why?
|
Scalp | 1 | 2021 | 391 | 0.040 |
Why?
|
S100 Proteins | 1 | 2018 | 216 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10266 | 0.040 |
Why?
|
Vimentin | 1 | 2018 | 257 | 0.040 |
Why?
|
Thermodynamics | 1 | 1999 | 591 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2002 | 947 | 0.040 |
Why?
|
Aneuploidy | 1 | 2001 | 573 | 0.040 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2019 | 119 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 24315 | 0.040 |
Why?
|
Radiation Injuries | 1 | 2024 | 1198 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11878 | 0.030 |
Why?
|
Benchmarking | 1 | 2023 | 1057 | 0.030 |
Why?
|
Iodine Radioisotopes | 1 | 2020 | 1034 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4912 | 0.030 |
Why?
|
Drainage | 2 | 2014 | 1183 | 0.030 |
Why?
|
Scleritis | 1 | 2017 | 96 | 0.030 |
Why?
|
Administration, Oral | 1 | 2024 | 4030 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8744 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1999 | 1683 | 0.030 |
Why?
|
Craniotomy | 1 | 2000 | 736 | 0.030 |
Why?
|
Lymphoma | 1 | 2024 | 1898 | 0.030 |
Why?
|
Retinal Detachment | 1 | 2019 | 429 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2021 | 1140 | 0.030 |
Why?
|
Nasal Septum | 1 | 2016 | 131 | 0.030 |
Why?
|
Aspergillus | 1 | 2015 | 95 | 0.030 |
Why?
|
Head | 1 | 2021 | 926 | 0.030 |
Why?
|
Parotitis | 1 | 2014 | 28 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2001 | 1613 | 0.030 |
Why?
|
Delphi Technique | 1 | 2019 | 891 | 0.030 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2016 | 748 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 1999 | 1951 | 0.030 |
Why?
|
Hyperbaric Oxygenation | 1 | 2015 | 166 | 0.030 |
Why?
|
Optic Nerve | 1 | 2017 | 571 | 0.030 |
Why?
|
Travel | 1 | 2000 | 805 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4176 | 0.030 |
Why?
|
Cloprostenol | 1 | 2013 | 21 | 0.030 |
Why?
|
Prostaglandins F, Synthetic | 1 | 2013 | 32 | 0.030 |
Why?
|
Child, Preschool | 5 | 2016 | 42669 | 0.030 |
Why?
|
Melanocytes | 1 | 2016 | 509 | 0.030 |
Why?
|
Meningitis | 1 | 2014 | 219 | 0.030 |
Why?
|
Pharyngitis | 1 | 2014 | 222 | 0.030 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 662 | 0.030 |
Why?
|
Cohort Studies | 1 | 2015 | 41754 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1826 | 0.030 |
Why?
|
Polymers | 1 | 2019 | 1630 | 0.020 |
Why?
|
Lymphatic Vessels | 1 | 2016 | 356 | 0.020 |
Why?
|
Tumor Burden | 1 | 2017 | 1906 | 0.020 |
Why?
|
Ketone Bodies | 1 | 1991 | 76 | 0.020 |
Why?
|
Prednisone | 1 | 2016 | 1567 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2004 | 3840 | 0.020 |
Why?
|
Clavulanic Acid | 1 | 2010 | 19 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 2016 | 1264 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2014 | 1609 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2000 | 1761 | 0.020 |
Why?
|
Pneumonia | 1 | 2002 | 2163 | 0.020 |
Why?
|
Amides | 1 | 2013 | 451 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 22291 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2014 | 942 | 0.020 |
Why?
|
Prednisolone | 1 | 2011 | 326 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 1991 | 394 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2013 | 404 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3437 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9384 | 0.020 |
Why?
|
Ocular Motility Disorders | 1 | 2011 | 144 | 0.020 |
Why?
|
Brachytherapy | 1 | 2017 | 1220 | 0.020 |
Why?
|
Growth Hormone | 1 | 1991 | 573 | 0.020 |
Why?
|
Amoxicillin | 1 | 2010 | 182 | 0.020 |
Why?
|
Registries | 2 | 2024 | 8375 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2001 | 1926 | 0.020 |
Why?
|
Positron-Emission Tomography | 2 | 2017 | 6669 | 0.020 |
Why?
|
Contrast Media | 1 | 2002 | 5330 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2002 | 9015 | 0.020 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2010 | 342 | 0.020 |
Why?
|
DNA | 1 | 2001 | 7214 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4329 | 0.020 |
Why?
|
Demography | 1 | 1992 | 1641 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26379 | 0.020 |
Why?
|
Mutation | 2 | 2024 | 30238 | 0.020 |
Why?
|
Protein Binding | 1 | 1999 | 9343 | 0.020 |
Why?
|
Incidence | 2 | 2024 | 21538 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9615 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2016 | 1402 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3912 | 0.020 |
Why?
|
Hypothalamus | 1 | 1991 | 1004 | 0.020 |
Why?
|
Seasons | 1 | 1992 | 1524 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2011 | 2230 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 1992 | 807 | 0.020 |
Why?
|
Risk Factors | 6 | 2015 | 74944 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 9092 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8741 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2001 | 8647 | 0.020 |
Why?
|
Pain | 1 | 2019 | 5100 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15948 | 0.010 |
Why?
|
Muscle Relaxation | 1 | 2004 | 138 | 0.010 |
Why?
|
Functional Laterality | 1 | 2011 | 2264 | 0.010 |
Why?
|
Software | 1 | 2017 | 4478 | 0.010 |
Why?
|
Diet | 1 | 2000 | 8089 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2001 | 6974 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 12800 | 0.010 |
Why?
|
DNA Fingerprinting | 1 | 2001 | 114 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18349 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12077 | 0.010 |
Why?
|
Glucose | 1 | 1991 | 4352 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2107 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2002 | 2512 | 0.010 |
Why?
|
Northwest Territories | 1 | 1993 | 1 | 0.010 |
Why?
|
Animals | 3 | 2020 | 169246 | 0.010 |
Why?
|
Mice | 1 | 2020 | 82029 | 0.010 |
Why?
|
Swine | 1 | 2002 | 5995 | 0.010 |
Why?
|
Nicotinic Acids | 1 | 1991 | 33 | 0.010 |
Why?
|
Image Enhancement | 1 | 2002 | 2880 | 0.010 |
Why?
|
Hydroxybutyrates | 1 | 1991 | 76 | 0.010 |
Why?
|
Oleic Acids | 1 | 1991 | 71 | 0.010 |
Why?
|
Injections, Intraventricular | 1 | 1991 | 227 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2004 | 12465 | 0.010 |
Why?
|
Indians, North American | 1 | 1993 | 354 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2001 | 15454 | 0.000 |
Why?
|
Macaca mulatta | 1 | 1991 | 2363 | 0.000 |
Why?
|
Rectal Neoplasms | 1 | 1993 | 1183 | 0.000 |
Why?
|
Neoplasms | 1 | 1993 | 22371 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1991 | 1841 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1993 | 2541 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1993 | 2043 | 0.000 |
Why?
|
Insulin | 1 | 1991 | 6607 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 1993 | 11101 | 0.000 |
Why?
|